title: Infliximab vs. Adalimumab for Crohn's disease.
authors.forename: P
authors.initials: P
authors.lastname: Mulani
authors.forename: J
authors.initials: J
authors.lastname: Chao
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D003362:Cost-Benefit Analysis; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab